Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Download this complimentary Expert Insights eBook today!

Bio-Rad Acquires Stilla Technologies

Bio-Rad Laboratories, a life science research and clinical diagnostics company, has completed the acquisition of Stilla Technologies, a developer of digital PCR (dPCR) systems.

Top-Feature

Nova-Institut GmbH

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Bio-Rad Laboratories

Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Bio-Rad Acquires Stilla Technologies

Top-Feature

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

Anchored in Sustainability

Leading Transformation

Europe’s Biotech Inflection Point

Leading the way. Driving results.

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

API Manufacturing

Driving Sustainability Through Collaboration

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Interview

Leading Transformation

Newsletter & e-edition